Case-control study comparing de novo and daptomycin-exposed daptomycin-nonsusceptible enterococcus infections

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2150-2152

  Kelesidis, Theodoros ^a   Chow, Angela L P ^b,c   Humphries, Romney ^a   Uslan, Daniel Z ^a   Pegues, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; GENTAMICIN; LINEZOLID; NITROFURANTOIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS GALLINARUM; HOSPITALIZATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DAPTOMYCIN; DISEASE RESERVOIRS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS; ODDS RATIO; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84858690218     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05918-11     Document Type: Article

References (12)

1. Ballard SA, Grabsch EA, Johnson PD, Grayson ML. 2005. Comparison of three PCR primer sets for identification of vanB gene carriage in feces and correlation with carriage of vancomycin-resistant enterococci: interference by vanB-containing anaerobic bacilli. Antimicrob. Agents Chemother. 49:77-81. (Pubitemid 40065775)
2. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 8th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Goldstein EJC, et al. 2003. In vitro activities of daptomycin, vancomycin, quinupristin-dalfopristin, linezolid, and five other antimicrobials against 307 Gram-positive anaerobic and 31 Corynebacterium clinical isolates. Antimicrob. Agents Chemother. 47:337-341. (Pubitemid 36074932)
6. Hume ME, Poole TL, Pultz NJ, Hanrahan JA, Donskey CJ. 2004. Inhibition of vancomycin-resistant enterococcus by continuous-flow cultures of human stool microflora with and without anaerobic gas supplementation. Curr. Microbiol. 48:364-367. (Pubitemid 38507017)
7. Jorgensen JH, Crawford SA. 2006. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs. J. Clin. Microbiol. 44:2126-2129. (Pubitemid 43902163)
8. Kelesidis T, Humphries R, Pegues DA. 2011. Case series of daptomycin nonsusceptible Enterococcus infections with no prior daptomycin exposure in a tertiary center, abstr 204. Abstr. 49th Annu. Meet. Infect. Dis. Soc. Am. (IDSA). Boston, MA, 22 October 2011.
9. Kelesidis T, Humphries R, Pegues DA. Daptomycin non-susceptible Enterococcus infections can develop in the absence of prior antimicrobial exposure, abstr 873. Abstr. 49th Annu. Meet. Infect. Dis. Soc. Am. (IDSA). Boston, MA, 22 October 2011.
10. Kelesidis T. 2011. Comment on: successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections. J. Antimicrob. Chemother. 67:515-516.
11. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin. Infect. Dis. 52:228-234.
12. Sun Y, Smith E, Wolcott R, Dowd SE. 2009. Propagation of anaerobic bacteria within an aerobic multi-species chronic wound biofilm model. J. Wound Care. 18:426-431.